Helen D. Eshed, MD

Originally from Tennessee, Dr. Eshed’s love for travel permeated her experiences in university and training. Dr. Eshed attended Dartmouth College in New Hampshire before going on to medical school at Albany Medical College in New York. She then finished her residency at the University of California Davis. After completing her fellowship training in Gynecologic Oncology at Columbia University and Weill Cornell Medical College in New York, NY she came to Austin, Texas to start her career and her f

Dr. Eshed is board-certified in obstetrics and gynecology as well as gynecologic oncology. She specializes in the diagnosis, treatment and management of women with gynecologic cancers including cervical, uterine or endometrial, ovarian, vulvar and vaginal cancers as well as gestational trophoblastic disease. Her special interests include research and clinical trials to improve patient outcomes and quality of life. She also educates providers in the community on the newest statistics and advancements in gynecologic oncology treatment and care.

Dr. Eshed provides specialized care while using the latest research and technology to create a comprehensive individualized treatment plan for each of her patients. She is a part of an expert care team at Texas Oncology, working together to help each patient from diagnosis and treatment to survivorship. Her focus for each patient is to provide the best possible care in a supportive, comfortable environment. She treats every patient the way she would treat her mother, sister or daughter. In addition to supporting her patients, Dr. Eshed also spends her personal time participating in charitable cancer related organizations like the Flatwater Foundation and Wonders and Worries. Both organizations not only support the patient, but the family members of the patient, another crucial aspect to the type of care Dr. Eshed provides at Texas Oncology.

Dr. Eshed is actively involved in clinical trials to individualize patient care and improve patients’ outcomes and quality of life. She has authored over a dozen peer-reviewed publications and presents lectures nationally and internationally on research in gynecologic cancers. She was the recipient of the American Society of Clinical Oncology (ASCO) Young Investigator Award grant for her research efforts in minimally invasive gynecologic cancer surgery.

Dr. Eshed is the principal investigator in USOR 17052 using an anti-PD1 monoclonal antibody REGN2810 vs. investigator’s choice chemotherapy for metastatic or recurrent platinum resistant cervical cancer.